Givner L B, Abramson J S, Wasilauskas B
Department of Pediatrics, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina 27103.
Rev Infect Dis. 1989 Mar-Apr;11(2):329-34. doi: 10.1093/clinids/11.2.329.
Invasive disease due to Haemophilus influenzae type b (Hib) resistant to chloramphenicol and ampicillin is rare in the United States. Review of the literature reveals that all previously reported cases occurred in children with meningitis. These children were treated initially with ampicillin and chloramphenicol and had complicated courses characterized by delayed sterilization of the cerebrospinal fluid. The present report describes an infant who developed meningitis due to ampicillin- and chloramphenicol-resistant Hib. The patient received cefotaxime from the onset of therapy and had an uncomplicated course. The presence of Hib strains resistant to chloramphenicol and ampicillin should be considered in patients with meningitis due to Hib who respond poorly to treatment with these two drugs. Furthermore, the in vitro susceptibility of all Hib isolates to chloramphenicol (as well as to other antimicrobial agents) should be evaluated routinely. If the incidence of such resistant organisms increases, a change will be warranted in the commonly recommended combination of ampicillin and chloramphenicol as empiric therapy for bacterial meningitis in pediatric patients.
在美国,对氯霉素和氨苄西林耐药的b型流感嗜血杆菌(Hib)引起的侵袭性疾病较为罕见。文献回顾显示,所有先前报告的病例均发生在患脑膜炎的儿童中。这些儿童最初接受氨苄西林和氯霉素治疗,病程复杂,其特点是脑脊液灭菌延迟。本报告描述了一名因对氨苄西林和氯霉素耐药的Hib而患脑膜炎的婴儿。该患者从治疗开始就接受头孢噻肟治疗,病程顺利。对于因Hib引起脑膜炎且对这两种药物治疗反应不佳的患者,应考虑存在对氯霉素和氨苄西林耐药的Hib菌株。此外,应常规评估所有Hib分离株对氯霉素(以及其他抗菌药物)的体外敏感性。如果此类耐药菌的发生率增加,那么对于儿科患者细菌性脑膜炎的经验性治疗,常用的氨苄西林和氯霉素联合用药就有必要改变。